Option chain shows key data for Bellicum Pharmaceuticals Inc's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bellicum Pharmaceuticals Inc.

Bellicum Pharmaceuticals Inc (OTC:BLCM) Stock, Option Chain

Bellicum Pharmaceuticals

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMBA

ARDS

AUMN

BDRX

BHAT

BJDX

BLCM

BLTE

CGAU

CPRI

CVNA

CXAI

EEIQ

GTBP

HRZN

INTC

IVVD

KAVL

LAES

LPTV

LTRX

LYEL

MRKR

NNOX

PBLA

PLMR

QTEK

SOFI

SPWH

TENX

UHAL

UTME

VTGN

WEJO

WLDS

WLGS

XELA

Gainers


	Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.


Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Pre-Market Outlook

ACON

ACRX

ASPI

EGIO

MCOM

NCPL

RCRT

Gainers


	VIQ Solutions Inc.  (NASDAQ: VQS) shares rose 66.8% to $0.3887 in pre-market trading.


Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket

AIRS

ARLO

ARRY

BIOL

BLBD

BNMV

CDTX

CETX

CHEK

DRMA

FRGT

FSLR

GBNH

GETR

GSIT

HALL

HEPA

HLLY

HROW

HRTX

IBRX

IMPL

INTZ

IONM

IONQ

JWAC

MRNS

OSUR

OUST

PHAR

PIII

RCEL

SPRY

SURG

UFAB

VCIG

VYNE

Gainers


	GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.


Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Bellicum Pharmaceuticals Inc

<h3>Gainers</h3>
<ul>
<li>Minerva Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTRS#NASDAQ">UTRS</a>) shares increased by 111.8% to $0.42 during Friday's regular session. As of 13:30 EST, Minerva Surgical's stock is trading at a volume of 85.0 million, which is 3814.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $74.9 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) stock rose 20.44% to $2.18. CNS Pharma's stock is trading at a volume of 1.6 million shares as of 13:30 EST. This is 48.5% of its average full-day volume over the last 100 days. The company's market cap stands at $9.0 million. </li>
<li>Kala Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) stock moved upwards by 18.57% to $17.62. As of 13:30 EST, this security is trading at a volume of 196.9K shares, making up 33.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $41.3 million. </li>
<li>Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) stock moved upwards by 18.57% to $1.04. As of 13:30 EST, this security is trading at a volume of 1.3 million shares, making up 82.8% of its average full-day volume over the last 100 days. The company's market cap stands at $64.5 million. </li>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) shares rose 18.53% to $0.41. Trading volume for this security as of 13:30 EST is 91.6K, which is 207.8% of its average full-day volume over the last 100 days. The company's market cap stands at $10.8 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCCP#NASDAQ">CYCCP</a>) shares increased by 18.23% to $12.97. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bellicum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCM#NASDAQ">BLCM</a>) shares declined by 63.7% to $0.25 during Friday's regular session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Kiora Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPRX#NASDAQ">KPRX</a>) shares fell 49.85% to $0.83. As of 13:30 EST, this security is trading at a volume of 3.6 million shares, making up 5902.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 million. </li>
<li>Oncorus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCR#NASDAQ">ONCR</a>) shares fell 40.99% to $0.11. Trading volume for this security as of 13:30 EST is 3.6 million, which is 1320.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.7 million. </li>
<li>Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) stock decreased by 19.15% to $7.73. Sight Sciences's stock is trading at a volume of 273.4K shares as of 13:30 EST. This is 248.7% of its average full-day volume over the last 100 days. The company's market cap stands at $374.5 million. </li>
<li>Cue Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) shares declined by 16.0% to $0.6. Trading volume for this security as of 13:30 EST is 1.0 million, which is 252.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $91.0 million. </li>
<li>Trxade Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) stock declined by 15.28% to $0.33. Trading volume for Trxade Health's stock is 376.2K as of 13:30 EST. This is 93.4% of its average full-day volume over the last 100 days. The company's market cap stands at $3.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNSP

CYCCP

HLTH

KALA

Kiora Pharmaceuticals, Inc. - Common Stock

KPRX

KTTA

MEDS

ONCR

PRAX

SGHT

UTRS

12 Health Care Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Aridis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ards#NASDAQ">ARDS</a>) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bjdx#NASDAQ">BJDX</a>) gained 67% to $0.3225.</li>
<li>VIQ Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vqs#NASDAQ">VQS</a>) shares jumped 49.1% to $0.3474.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) climbed 31% to $1.73 after the company reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) rose 30% to $0.4151. Tenax Therapeutics achieved major milestone as USPTO granted notice of allowance for U.S. patent application covering use of oral levosimendan in pulmonary hypertension with heart failure with preserved ejection fraction.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) shares gained 19.4% to $0.1599 after the company announced it will present fasedienol safety and exploratory efficacy data from its Phase 3 open-label social anxiety disorder study at the ASCP 2023 Annual Meeting.</li>
<li>LL Flooring Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) shares climbed 18.8% to $4.92. LL Flooring confirmed the receipt of $5.76 per share unsolicited, non-binding proposal from Cabinets To Go, a subsidiary of F9 Brands.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) gained 17.5% to $13.06.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) climbed 17.4% to $0.6574. Kaival Brands acquired Extensive vaporizer and inhalation patent portfolio to diversify product offerings and create new revenue opportunities.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) gained 16% to $1.78.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) rose 14% to $1.5850 after declining around 5% on Tuesday.</li>
<li>Loop Media, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lptv#NYSE">LPTV</a>) surged 13.3% to $3.67.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) gained 12.7% to $5.33.</li>
<li>Nano-X Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nnox#NASDAQ">NNOX</a>) climbed 12.7% to $19.23.</li>
<li>Chindata Group Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cd#NASDAQ">CD</a>) gained 11.1% to $5.59 after reporting first-quarter results.</li>
<li>Lyell Immunopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyel#NASDAQ">LYEL</a>) shares rose 10.8% to $3.0595.</li>
<li>Palomar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>) gained 10.6% to $52.30 as the company announced successful completion of June 1 reinsurance renewal and raised full year 2023 adjusted net income guidance.</li>
<li>Centerra Gold Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cgau#NYSE">CGAU</a>) surged 10.3% to $6.03.</li>
<li>SoFi Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sofi#NASDAQ">SOFI</a>) gained 10% to $6.64 following a tentative debt limit agreement, which would reinstate student loan payments.</li>
<li>Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) surged 6% to $31.76 amid the company&#39;s presentation at TD Cowen&#39;s 51st Annual Technology, Media &amp; Telecom Conference.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>QualTek Services Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtek#NASDAQ">QTEK</a>) fell 41.3% to $ 0.0880 after the company received Nasdaq delisting notice.</li>
<li>Belite Bio, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blte#NASDAQ">BLTE</a>) shares dipped 33.2% to $15.70 after the company reported pricing of a $30 million underwritten public offering of ADSs and warrants.</li>
<li>Advance Auto Parts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aap#NYSE">AAP</a>) fell 33.2% to $74.98 after the company reported worse-than-expected first-quarter financial results and cut FY23 guidance below estimates.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) shares dropped 39.5% to $0.0821. Biodexa Pharmaceuticals recently reported closing of $3.32 million registered direct offering.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) fell 37% to $0.2138. Panbela announced a 1-for-30 reverse stock split effective June 1, 2023.</li>
<li>Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>) dropped 26.9% to $0.1155. Golden Minerals Company company announced a 1-for-25 reverse stock split.</li>
<li>Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhat#NASDAQ">BHAT</a>) fell 22.1% to $0.95.</li>
<li>Wejo Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wejo#NASDAQ">WEJO</a>) fell 18.2% to $0.1012. Wejo Group shares dipped 57% on Tuesday after the company said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US.</li>
<li>Lantronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrx#NASDAQ">LTRX</a>) dropped 18.1% to $4.30. Lantronix said Paul Pickle will be resigning from his role as President and CEO.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) fell 17.1% to $1.5250. Wearable Devices last week announced its Mudra Band for Apple Watch is available for preorder.</li>
<li>EpicQuest Education Group International Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eeiq#NASDAQ">EEIQ</a>) dropped 17% to $2.05.</li>
<li>Ambarella Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amba#NASDAQ">AMBA</a>) fell 15.9% to $68.98 after the company issued a weak second-quarter forecast.</li>
<li>Sportsman&#39;s Warehouse Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwh#NASDAQ">SPWH</a>) fell 15.3% to $4.65 as the company posted a wider-than-expected loss for its first quarter and issued weak forecast for the current quarter.</li>
<li>Hovnanian Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hov#NYSE">HOV</a>) fell 14.5% to $80.21 after reporting second-quarter results. Hovnanian Enterprises also said it sees FY23 revenue of $2.5 billion to $2.65 billion and FY23 EPS of $17 to $20.</li>
<li>GT Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtbp#NASDAQ">GTBP</a>) dropped 13.7% to $0.2173.</li>
<li>SEALSQ Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/laes#NASDAQ">LAES</a>) fell 13.2% to $11.80.</li>
<li>TOP Financial Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/top#NYSE">TOP</a>) dropped 11.8% to $9.14.</li>
<li>U-Haul Holding Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uhal#NYSE">UHAL</a>) fell 11.6% to $55.70 after the company reported worse-than-expected Q1 results.</li>
<li>Capri Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpri#NYSE">CPRI</a>) dropped 10.8% to $35.28 following fourth-quarter results. Capri sees first-quarter revenue of ~$1.2 billion against the Street view of $1.3 billion and sees EPS of $0.70.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) fell 10.5% to $39.35 mid profit taking following a rally in AI stocks.</li>
<li>Horizon Technology Finance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrzn#NASDAQ">HRZN</a>) shares fell 10.4% to $11.89. Horizon Technology Finance priced an underwritten public offering of 3,250,000 shares at a price of $12.50 per share for total gross proceeds of around $40,625000.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 10.1% to $0.6898.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) dropped 9.7% to $12.39. JMP Securities reiterated Carvana with a Market Outperform and maintained a $15 price target.</li>
<li>UTime Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/utme#NASDAQ">UTME</a>) fell 9.4% to $1.3597 after jumping 30% on Tuesday.</li>
<li>Chico&#39;s FAS, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chs#NYSE">CHS</a>) dropped 8.7% to $4.71. Telsey Advisory Group reiterated Chico&#39;s FAS with a Market Perform and maintained a $6 price target.</li>
<li>Donaldson Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dci#NYSE">DCI</a>) fell 8.1% to $58.92. Donaldson reported a third-quarter FY23 sales increase of 2.6% Y/Y to $875.7 million beating the consensus of $868.4 million. The company now expects FY23 adjusted EPS to be $3.00-$3.06 (vs $2.99-$3.07 previously) compared to the consensus of $3.04.</li>
<li>Hewlett Packard Enterprise Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hpe#NYSE">HPE</a>) shares declined 6.4% to $14.53 after reporting downbeat second-quarter sales.</li>
<li>Frontline Plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) shares declined 4.9% to $14.30 following first-quarter results.</li>
<li>HP Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hpq#NYSE">HPQ</a>) shares dropped 3.2% to $29.93. HP reported better-than-expected earnings for its second quarter, while sales missed expectations.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/05/32648620/bitcoin-drops-but-remains-above-this-key-level-optimism-conflux-among-top-losers"> Bitcoin Drops But Remains Above This Key Level; Optimism, Conflux Among Top Losers</a>

Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Aridis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDS#NASDAQ">ARDS</a>) shares increased by 98.9% to $0.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.2 million. </li>
<li>VistaGen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTGN#NASDAQ">VTGN</a>) stock increased by 38.98% to $0.19. The market value of their outstanding shares is at $40.8 million. </li>
<li>Marker Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRKR#NASDAQ">MRKR</a>) shares increased by 30.83% to $1.74. The market value of their outstanding shares is at $15.3 million. </li>
<li>Tenax Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENX#NASDAQ">TENX</a>) stock moved upwards by 25.06% to $0.4. The market value of their outstanding shares is at $8.7 million. </li>
<li>Freeline Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRLN#NASDAQ">FRLN</a>) shares moved upwards by 15.99% to $2.9. The market value of their outstanding shares is at $12.5 million. The company's, Q1 earnings came out yesterday. </li>
<li>Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) shares rose 15.79% to $1.11. The market value of their outstanding shares is at $206.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) stock fell 44.0% to $13.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $337.7 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) shares declined by 32.82% to $0.09. The company's market cap stands at $1.7 million. </li>
<li>Bellicum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCM#NASDAQ">BLCM</a>) shares decreased by 25.09% to $0.57. The company's market cap stands at $5.4 million. </li>
<li>NeuBase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBSE#NASDAQ">NBSE</a>) stock decreased by 19.93% to $0.14. The company's market cap stands at $4.7 million. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock declined by 15.86% to $0.88. The market value of their outstanding shares is at $6.9 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) stock decreased by 13.9% to $3.47. The company's market cap stands at $5.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKBA

FRLN

NBSE

PHIO

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>VIQ Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vqs#NASDAQ">VQS</a>) shares rose 66.8% to $0.3887 in pre-market trading.</li>
<li>Appreciate Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfr#NASDAQ">SFR</a>) shares surged 59% to $0.4307 in pre-market trading after dropping 14% on Tuesday.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) shares rose 50% to $0.2009 in pre-market trading. Vistagen will present fasedienol safety and exploratory efficacy data from Phase 3 Open-label social anxiety disorder study at the American Society for Clinical Psychopharmacology Annual Meeting.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) gained 27.3% to $1.77 in pre-market trading after declining around 5% on Tuesday.</li>
<li>LL Flooring Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) shares gained 19.1% to $4.93 in pre-market trading. LL Flooring confirmed the receipt of $5.76 per share unsolicited, non-binding proposal from Cabinets To Go, a subsidiary of F9 Brands.</li>
<li>Edgio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egio#NASDAQ">EGIO</a>) rose 14.1% to $0.5650 in pre-market trading.</li>
<li>Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) rose 13.2% to $1.54 in pre-market trading after gaining 7% on Tuesday. Mobilicom recently received a purchase order for its end-to-end product solution that will be installed into autonomous and remote-controlled electric vehicles for homeland security and defense.</li>
<li>Netcapital Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncpl#NASDAQ">NCPL</a>) gained 10.1% to $1.42 in pre-market trading after declining 7% on Tuesday. The company recently reported closing of registered direct offering.</li>
<li>Micromobility.com Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcom#NASDAQ">MCOM</a>) shares climbed 10.1% to $0.40 in pre-market trading after dropping around 6% on Tuesday. The company recently posted a rise in quarterly sales.</li>
<li>Recruiter.com Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcrt#NASDAQ">RCRT</a>) shares gained 9.6% to $0.2465 in pre-market trading after gaining 4% on Tuesday. Recruiter.com, last month, announced the launch of Candidate Pitch, an AI web application.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Belite Bio, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blte#NASDAQ">BLTE</a>) fell 37.2% to $14.76 in pre-market after the company reported pricing of $30 million underwritten public offering of American Depositary Shares and warrants.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) shares dropped 31.6% to $0.0928 in pre-market trading. Biodexa Pharmaceuticals recently reported closing of $3.32 million registered direct offering.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 26.1% to $0.5675 in pre-market trading.</li>
<li>QualTek Services Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtek#NASDAQ">QTEK</a>) fell 19.3% to $0.12 in pre-market trading after jumping 96% on Tuesday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.</li>
<li>Wejo Group Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wejo#NASDAQ">WEJO</a>) fell 19.2% to $0.10 in pre-market trading. Wejo Group shares dipped 57% on Tuesday after the company said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US.</li>
<li>AcelRx Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrx#NASDAQ">ACRX</a>) fell 18.6% to $0.80 in pre-market trading after declining 11% on Tuesday. AcelRx Pharmaceuticals recently posted a narrower-than-expected quarterly loss.</li>
<li>Ambarella Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amba#NASDAQ">AMBA</a>) fell 17.9% to $67.30 in pre-market trading after the company issued a weak second-quarter forecast.</li>
<li>ASP Isotopes Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aspi#NASDAQ">ASPI</a>) shares fell 13.5% to $0.30 in pre-market trading after gaining 6% on Tuesday.</li>
<li>UTime Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/utme#NASDAQ">UTME</a>) fell 12.7% to $1.31 in pre-market trading after jumping 30% on Tuesday.</li>
<li>Aclarion Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) fell 10.5% to $0.94 in pre-market trading. Aclarion shares jumped 78% on Tuesday after the company announced a commercial agreement with the London Clinic and London Spine Clinic.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/05/32640978/investor-optimism-declines-after-dow-settles-lower"> Investor Optimism Declines After Dow Settles Lower</a>

<h3>Gainers</h3>
<ul>
<li>GSI Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsit#NASDAQ">GSIT</a>) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.</li>
<li>ARS Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spry#NASDAQ">SPRY</a>) shares jumped 82.8% to $8.27 after the company reported the FDA&#39;s Advisory Committee voted in support of favorable benefit-risk assessment for neffy in the treatment of severe allergic reactions (Type 1), including anaphylaxis.</li>
<li>Getaround, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/getr#NYSE">GETR</a>) shares climbed 73.6% to $0.5749 after the company announced it is acquiring substantially all of the assets of HyreCar for an aggregate purchase price of $9.45 million.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) shares climbed 45.1% to $2.80 after the company highlighted recent corporate progress, and reported financial results for the first quarter.</li>
<li>Jupiter Wellness Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jwac#NASDAQ">JWAC</a>) surged 40% to $7.10.</li>
<li>Blue Bird Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blbd#NASDAQ">BLBD</a>) gained 38.7% to $26.80 after the company reported better-than-expected Q2 results.</li>
<li>AirSculpt Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/airs#NASDAQ">AIRS</a>) shares climbed 32.8% to $6.50 after the company reported better-than-expected Q1 financial results.</li>
<li>Arlo Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arlo#NASDAQ">ARLO</a>) gained 24.3% to $8.76 following strong quarterly results.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) rose 23.2% to $0.77.</li>
<li>First Solar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fslr#NASDAQ">FSLR</a>) surged 21.9% to $223.36 after the company announced the acquisition of Evolar.</li>
<li>Ouster, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) gained 19.3% to $4.58 following strong Q1 sales results.</li>
<li>VYNE Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vyne#NASDAQ">VYNE</a>) gained 19.3% to $7.28 after the company reported Q1 financial results.</li>
<li>Array Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arry#NASDAQ">ARRY</a>) jumped 18.6% to $22.47 following strong quarterly results.</li>
<li>SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) gained 14.7% to $5.06 after the company reported Q1 financial results.</li>
<li>Pharming Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phar#NASDAQ">PHAR</a>) rose 14.5% to $11.69. Pharming recently posted a Q1 loss of $0.02 per share.</li>
<li>P3 Health Partners Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/piii#NASDAQ">PIII</a>) jumped 14.3% to $2.64. P3 Health Partners recently posted upbeat quarterly results.</li>
<li>Holley Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlly#NYSE">HLLY</a>) gained 12.8% to $3.07. Telsey Advisory Group and Raymond James raised their price targets on the stock.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdtx#NASDAQ">CDTX</a>) rose 9.3% to $1.29 following better-than-expected quarterly sales.</li>
<li>Hallmark Financial Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hall#NASDAQ">HALL</a>) gained 9.1% to $4.31.</li>
<li>News Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nws#NASDAQ">NWS</a>) surged 6.7% to $17.97 following Q3 results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Assure Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionm#NASDAQ">IONM</a>) fell 37.8% to $1.20 after the company announced pricing of a $6 million underwritten public offering.</li>
<li>Heron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrtx#NASDAQ">HRTX</a>) dropped 33.9% to $1.4750 after the company reported mixed Q1 financial results.</li>
<li>TOP Financial Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/top#NASDAQ">TOP</a>) shares fell 29.7% to $6.42 after the SEC said it is temporarily suspending trading in the securities of the company because of &quot;recent, unusual, and unexplained market activity&quot; raising concerns regarding the adequacy and accuracy of publicly-available information.</li>
<li>AVITA Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcel#NASDAQ">RCEL</a>) dropped 24.3% to $11.89 after the company reported mixed Q1 financial results.</li>
<li>Freight Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frgt#NASDAQ">FRGT</a>) declined 23% to $1.54 after the company reported preliminary Q1 2023 revenue of $3.3 million, down from $5.3 million for Q1 prior year 2022.</li>
<li>Intrusion Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intz#NASDAQ">INTZ</a>) dropped 22.9% to $1.31 following weak quarterly results.</li>
<li>BitNile Metaverse, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnmv#NASDAQ">BNMV</a>) fell 22.3% to $0.0449 after the company announced a 1-for-30 reverse stock split.</li>
<li>Audacy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aud#NYSE">AUD</a>) dropped 20.6% to $0.1086. Audacy recently reported mixed Q1 financial results.</li>
<li>Impel Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/impl#NASDAQ">IMPL</a>) fell 19.7% to $1.83 after the company reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.</li>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) dropped 19% to $1.49 following a wider-than-expected quarterly loss.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) fell 18.7% to $3.2820 after the company reported worse-than-expected Q1 sales results.</li>
<li>Hepion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hepa#NASDAQ">HEPA</a>) fell 18.5% to $6.74.</li>
<li>Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) dipped 18.4% to $0.4260. Akumin recently posted a wider quarterly loss.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) dropped 18% to $2.2850 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $10 to $4.</li>
<li>Hepion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hepa#NASDAQ">HEPA</a>) dipped 17% to $6.86.</li>
<li>Cemtrex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cetx#NASDAQ">CETX</a>) fell 16.5% to $9.10 after the company reported Q2 results.</li>
<li>Harrow Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrow#NASDAQ">HROW</a>) dropped 16.3% to $22.66 after the company reported Q1 financial results.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) fell 14.8% to $3.00 after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.</li>
<li>Youdao, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dao#NYSE">DAO</a>) dropped 14.4% to $5.42.</li>
<li>OraSure Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osur#NASDAQ">OSUR</a>) fell 13.8% to $6.37. OraSure Technologies recently posted upbeat quarterly results.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) dropped 12.5% to $9.19. Emergent BioSolutions recently reported better-than-expected Q1 sales results.</li>
<li>Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) declined 10.6% to $8.27. Marinus Pharmaceuticals reported Q1 financial results.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) shares fell 9.8% to $6.32 after the quantum computing company reported first-quarter financial results.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 9.7% to $0.7210. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.</li>
<li>Definitive Healthcare Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dh#NASDAQ">DH</a>) dropped 9% to $8.89.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 8.2% to $1.01 after gaining more than 5% on Thursday.</li>
<li>Unique Fabricating, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufab#NASDAQ">UFAB</a>) fell 7.4% to $0.2453 after dropping 16% on Thursday.</li>
<li>IHS Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) dropped 7.3% to $8.40.</li>
<li>BIOLASE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biol#NASDAQ">BIOL</a>) shares dropped 6.8% to $0.2236 after the company posted Q1 results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/05/32365962/bitcoin-tumbles-below-this-key-level-following-economic-data-pepe-huobi-token-among-top-lo"> Bitcoin Tumbles Below This Key Level Following Economic Data; Pepe, Huobi Token Among Top Losers</a>

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Getaround, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/getr#NYSE">GETR</a>) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) shares rose 35.2% to $2.61 in pre-market trading after the company highlighted recent corporate progress, and reported financial results for the first quarter.</li>
<li>Blue Bird Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blbd#NASDAQ">BLBD</a>) shares gained 30% to $25.16 in pre-market trading after the company reported better-than-expected Q2 results.</li>
<li>Rubicon Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbt#NYSE">RBT</a>) shares rose 19.5% to $0.5340 in pre-market trading after dropping around 15% on Thursday.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares gained 18.5% to $0.4979 in pre-market trading following Q1 results.</li>
<li>Babylon Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbln#NYSE">BBLN</a>) shares climbed 16% to $1.38 in pre-market trading after dropping 42% on Thursday. Babylon recently reported mixed Q1 financial results. The company also announced it secured financing and plans to implement a take private transaction with support from AlbaCore Capital.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdtx#NASDAQ">CDTX</a>) rose 13.4% to $1.34 in pre-market trading following better-than-expected quarterly sales.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) gained 12.5% to $3.39 in pre-market trading after reporting Q3 results.</li>
<li>OppFi Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/opfi#NYSE">OPFI</a>) rose 12.2% to $2.30 in pre-market trading as the company posted upbeat Q1 results and raised FY23 EPS guidance.</li>
<li>Ouster, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) gained 11.5% to $4.28 in pre-market trading following strong Q1 sales results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>VirnetX Holding Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vhc#NYSE">VHC</a>) fell 19.6% to $0.35 in pre-market after gaining around 15% on Thursday. VirnetX recently announced a partnership with Samsung.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 14.7% to $0.6824 in pre-market trading. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) fell 11.1% to $3.13 in pre-market trading after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) shares fell 11% to $0.7915 in pre-market trading. Addex Therapeutics shares dropped around 6% on Thursday after the company reported Q1 financial results.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 10.7% to $0.9808 in pre-market trading after gaining more than 5% on Thursday.</li>
<li>Austin Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aust#NYSE">AUST</a>) fell 10.2% to $1.06 in pre-market trading. Austin Gold reported the results of the 2023 Annual General Meeting.</li>
<li>Assure Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionm#NASDAQ">IONM</a>) fell 9.8% to $1.74 in pre-market trading after jumping 18% on Thursday. Assure Holdings recently reported preliminary first quarter 2023 financial results.</li>
<li>Red Cat Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcat#NASDAQ">RCAT</a>) fell 9.1% to $1.00 in pre-market trading. Red Cat recently received order for 200 long-range, high-speed drones for Ukrainian deployment.</li>
<li>Unique Fabricating, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufab#NASDAQ">UFAB</a>) fell 8.8% to $0.2418 in pre-market trading after dropping 16% on Thursday.</li>
<li>BIOLASE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biol#NASDAQ">BIOL</a>) shares dropped 8.3% to $0.22 in pre-market trading after the company posted Q1 results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/05/32358118/investor-sentiment-declines-further-after-dow-drops-for-fourth-consecutive-day"> Investor Sentiment Declines Further After Dow Drops For Fourth Consecutive Day</a>

ADXN

AUST

BBLN

Intelligent Bio Solutions Inc. - Common Stock

INBS

MNTS

OPFI

RCAT

Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>TScan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) stock rose 122.3% to $5.0 during Tuesday's regular session. The current volume of 41.6 million shares is 104202.1% of TScan Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $123.1 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) stock rose 37.04% to $10.21. The current volume of 33.2 million shares is 585.1% of Novavax's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $879.8 million. The company's, Q1 earnings came out today. </li>
<li>Voyager Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) stock moved upwards by 34.11% to $11.14. The current volume of 2.5 million shares is 845.4% of Voyager Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $484.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) stock increased by 32.99% to $4.58. As of 13:30 EST, Ensysce Biosciences's stock is trading at a volume of 24.8 million, which is 13244.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.8 million. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock moved upwards by 31.38% to $0.24. Trading volume for Venus Concept's stock is 3.5 million as of 13:30 EST. This is 1299.5% of its average full-day volume over the last 100 days. The company's market cap stands at $19.4 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock moved upwards by 28.16% to $4.05. As of 13:30 EST, Longeveron's stock is trading at a volume of 5.3 million, which is 24941.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) stock declined by 38.9% to $1.9 during Tuesday's regular session. Trevena's stock is trading at a volume of 18.9 million shares as of 13:30 EST. This is 1002.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.2 million. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) stock decreased by 26.95% to $0.75. As of 13:30 EST, Lexaria Bioscience's stock is trading at a volume of 1.0 million, which is 3758.6% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 million. </li>
<li>Enanta Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTA#NASDAQ">ENTA</a>) stock fell 26.86% to $25.11. Trading volume for Enanta Pharma's stock is 607.3K as of 13:30 EST. This is 338.6% of its average full-day volume over the last 100 days. The company's market cap stands at $524.4 million. The company's, Q2 earnings came out yesterday. </li>
<li>Bellicum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCM#NASDAQ">BLCM</a>) stock fell 26.56% to $0.71. Bellicum Pharmaceuticals's stock is trading at a volume of 4.0 million shares as of 13:30 EST. This is 141.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.3 million. </li>
<li>Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) shares declined by 26.48% to $5.99. Trading volume for Coherus BioSciences's stock is 3.5 million as of 13:30 EST. This is 346.8% of its average full-day volume over the last 100 days. The company's market cap stands at $482.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) stock decreased by 20.42% to $0.41. Trading volume for this security as of 13:30 EST is 2.4 million, which is 222.0% of its average full-day volume over the last 100 days. The company's market cap stands at $25.3 million. As per the press release, Q1 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHRS

ENSC

ENTA

LEXX

LGVN

NVAX

TCRX

TNXP

TRVN

VERO

VYGR

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>TScan Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrx#NASDAQ">TCRX</a>) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn&#39;s disease.</li>
<li>ClearOne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clro#NASDAQ">CLRO</a>) climbed 66.1% to $2.06 after the company announced a special one-time cash dividend of $1.00 per share of common stock, payable May 31 to shareholders of record on May 22, 2023.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) gained 52.8% to $5.26 after the company announced completion of PF614-MPAR-101, a clinical study examining its first pain medication with overdose protection, PF614-MPAR.</li>
<li>Mobiquity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobq#NASDAQ">MOBQ</a>) climbed 48.5% to $0.2302 after gaining around 7% on Monday.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) shares climbed 46.4% to $10.91 after the company reported mixed Q1 financial results and issued FY23 revenue guidance above estimates.</li>
<li>Neuronetics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stim#NASDAQ">STIM</a>) gained 37.3% to $3.02 after the company reported better-than-expected Q1 sales results, issued Q2 guidance and raised FY23 total worldwide revenue guidance.</li>
<li>Shengfeng Development Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfwl#NASDAQ">SFWL</a>) rose 26.7% to $5.62.</li>
<li>Y-mAbs Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymab#NASDAQ">YMAB</a>) climbed 25.6% to $8.51 following upbeat Q1 results.</li>
<li>VirnetX Holding Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vhc#NYSE">VHC</a>) surged 25.5% to $0.44 after the company announced a partnership with Samsung.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) gained 25.4% to $0.1630. Tivic Health, on Monday, launched a B2B portal.</li>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) shares rose 22.1% to $10.15 after reporting a profit for the first quarter.</li>
<li>Rover Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rovr#NASDAQ">ROVR</a>) gained 18.8% to $4.80 following strong quarterly results.</li>
<li>Palantir Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pltr#NYSE">PLTR</a>) surged 17.8% to $9.12 after the company reported strong Q1 results and said it expects to remain profitable each quarter through the end of the year.</li>
<li>Aris Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aris#NYSE">ARIS</a>) gained 17.5% to $8.47 following better-than-expected quarterly results.</li>
<li>Vivid Seats Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seat#NASDAQ">SEAT</a>) rose 17.1% to $9.24 after the company reported better-than-expected Q1 sales results and raised FY23 revenue guidance above estimates.</li>
<li>Maris-Tech Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtek#NASDAQ">MTEK</a>) gained 17% to $0.9805 after the company announced it entered into an agreement with Art of Logic Australia for $7.5 million of a new product based on the company&#39;s Uranus-AI product.</li>
<li>ERYTECH Pharma S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eryp#NASDAQ">ERYP</a>) rose 17% to $1.03 after the company provided a business and financial update for Q1.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) jumped 17% to $18.05 after the company reported better-than-expected Q1 financial results and issued guidance.</li>
<li>JELD-WEN Holding, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jeld#NYSE">JELD</a>) gained 16.8% to $14.71 following upbeat quarterly results.</li>
<li>Genius Sports Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/geni#NASDAQ">GENI</a>) rose 16.8% to $4.74 after the company posted upbeat quarterly sales and raised revenue outlook.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shls#NASDAQ">SHLS</a>) gained 16.4% to $22.96 after the company reported better-than-expected Q1 results and raised FY23 revenue guidance.</li>
<li>Intapp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inta#NASDAQ">INTA</a>) gained 16.4% to $44.16 after the company issued strong guidance. Multiple analysts raised their price targets on the stock following the report.</li>
<li>Alto Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alto#NASDAQ">ALTO</a>) climbed 15.4% to $1.57 after reporting Q1 results.</li>
<li>Target Hospitality Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/th#NASDAQ">TH</a>) rose 15.2% to $14.11 following Q1 results.</li>
<li>WaveDancer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wavd#NASDAQ">WAVD</a>) gained 13.7% to $0.58.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) rose 12.5% to $3.57. Longeveron announced new long-term survival data from ELPIS I trial of Lomecel-B for hypoplastic left heart syndrome.</li>
<li>DaVita Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>) gained 12.5% to $100.43 after the company reported better-than-expected Q1 results and raised its FY23 guidance.</li>
<li>Harmonic Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlit#NASDAQ">HLIT</a>) jumped 12.2% to $15.13 following upbeat quarterly earnings.</li>
<li>Assertio Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asrt#NASDAQ">ASRT</a>) rose 12.2% to $7.03 after the company reported better-than-expected Q1 financial results and raised guidance.</li>
<li>HUB Cyber Security (Israel) Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) gained 11.8% to $0.7154. HUB Security recently raised up to $16 million in growth investment from The Lind Partners.</li>
<li>MultiPlan Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpln#NYSE">MPLN</a>) gained 11.5% to $0.8721.</li>
<li>Natura &amp;Co Holding S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntco#NASDAQ">NTCO</a>) gained 10.5% to $4.93 following Q1 earnings.</li>
<li>Masonite International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/door#NYSE">DOOR</a>) climbed 8.2% to $100.48 after reporting strong quarterly results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ohmyhome Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) shares dipped 57.3% to $11.09 after jumping around 329% on Monday.</li>
<li>PRA Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/praa#NASDAQ">PRAA</a>) dropped 44.4% to $19.11 after the company reported a year-over-year decrease in Q1 EPS and sales results.</li>
<li>Tucows Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcx#NASDAQ">TCX</a>) fell 34.2% to $17.66 after posting a wider quarterly loss.</li>
<li>Trevena, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trvn#NASDAQ">TRVN</a>) dipped 33.4% to $2.07. Trevena is expected to release its financial results for the first quarter on May 15, 2023.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) fell 31.3% to $1.2510 after jumping 38% on Monday.</li>
<li>Enanta Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enta#NASDAQ">ENTA</a>) fell 30% to $24.00 after the company reported Q2 results and announced topline results from Phase 2 SPRINT trial evaluating EDP-235 in standard risk patients with COVID-19.</li>
<li>Shapeways Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shpw#NYSE">SHPW</a>) dropped 29% to $0.3121.</li>
<li>Lexaria Bioscience Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lexx#NASDAQ">LEXX</a>) fell 28.8% to $0.7302 after the company reported pricing of $2.0 million public offering.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 25.6% to $0.7140. Bellicum Pharmaceuticals shares jumped 146% on Monday after a 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company.</li>
<li>Coherus BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chrs#NASDAQ">CHRS</a>) fell 25% to $6.08 after the company reported worse-than-expected Q1 financial results.</li>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) fell 23.2% to $0.5994 after jumping around 60% on Monday.</li>
<li>Atara Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atra#NASDAQ">ATRA</a>) dropped 22.7% to $2.2950 following Q1 results.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) fell 21.8% to $0.3868 after gaining around 14% on Monday. Panbela Therapeutics recently posted a wider-than-expected quarterly loss.</li>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) dipped 21.6% to $0.4780.</li>
<li>CPI Card Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmts#NASDAQ">PMTS</a>) dropped 21.3% to $32.26 after the company reported Q1 financial results.</li>
<li>Nine Energy Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>) dipped 19.2% to $3.1854 after posting a Q1 loss.</li>
<li>Semrush Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/semr#NYSE">SEMR</a>) dropped 17.4% to $8.13 after the company reported mixed Q1 financial results and issued guidance.</li>
<li>Talos Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/talo#NYSE">TALO</a>) fell 16.3% to $11.01 after the company reported Q1 financial results.</li>
<li>Daseke, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dske#NASDAQ">DSKE</a>) dropped 15.7% to $6.36 after the company reported worse-than-expected Q1 financial results and issued guidance.</li>
<li>Aptorum Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apm#NASDAQ">APM</a>) fell 14% to $3.13 after dipping 32% on Monday.</li>
<li>Vertex Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NYSE">VTNR</a>) dipped 14% to $6.41 following weak quarterly results.</li>
<li>Arko Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arko#NASDAQ">ARKO</a>) fell 13.8% to $6.96 following downbeat quarterly results.</li>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) dropped 13.8% to $8.30 after the company reported Q1 financial results.</li>
<li>Clear Channel Outdoor Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cco#NYSE">CCO</a>) fell 12.5% to $1.10 after the company posted Q1 results and lowered FY23 revenue outlook.</li>
<li>The Hain Celestial Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hain#NASDAQ">HAIN</a>) dipped 11.4% to $15.59 after the company posted downbeat Q3 results and lowered FY23 outlook.</li>
<li>PayPal Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypl#NASDAQ">PYPL</a>) shares dropped 10.8% to $67.35 despite better-than-expected Q1 results.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 9.5% to $8.22 after the company reported downbeat Q1 results and announced next phase of restructuring initiative.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) dipped 9% to $0.8968 following weak quarterly sales.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) fell 8.7% to $7.04 after the company reported worse-than-expected Q1 results.</li>
<li>Maravai LifeSciences Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvi#NASDAQ">MRVI</a>) shares declined 6.8% to $12.95 after the company posted downbeat Q1 results and lowered 2023 outlook.</li>
<li>Skyworks Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swks#NASDAQ">SWKS</a>) shares fell 5.7% to $99.21 as the company reported downbeat earnings for its second quarter and issued weak sales forecast for the current quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/05/32291007/nasdaq-down-50-points-us-small-business-optimism-index-drops-in-april"> Nasdaq Down 50 Points; US Small Business Optimism Index Drops In April</a>

ALTO

ARIS

ARKO

ASRT

ATRA

CLRO

DOOR

DSKE

ERYP

GENI

HAIN

HLIT

HUBC

INTA

JCSE

JELD

LCID

MOBQ

MPLN

MRVI

MTEK

NINE

NKLA

NTCO

PLTR

PMTS

PRAA

PYPL

ROVR

SEAT

SEMR

SFWL

SHLS

SHPW

SKYT

STIM

SWKS

TALO

TIVC

VTNR

VVPR

WAVD

YMAB

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>TScan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) stock rose 61.8% to $3.64 during Tuesday's pre-market session. The company's market cap stands at $89.6 million. </li>
<li>Erytech Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERYP#NASDAQ">ERYP</a>) stock increased by 47.49% to $1.18. The company's market cap stands at $36.5 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) stock increased by 42.15% to $4.89. The market value of their outstanding shares is at $6.2 million. </li>
<li>Synlogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBX#NASDAQ">SYBX</a>) stock moved upwards by 23.21% to $0.69. The company's market cap stands at $46.7 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares rose 20.93% to $9.01. The company's market cap stands at $776.4 million. As per the press release, Q1 earnings came out today. </li>
<li>Tactile Systems Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) stock rose 17.12% to $21.95. The company's market cap stands at $509.9 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Enanta Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTA#NASDAQ">ENTA</a>) stock decreased by 30.3% to $23.93 during Tuesday's pre-market session. The company's market cap stands at $499.8 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) shares decreased by 27.81% to $0.74. The company's market cap stands at $4.4 million. </li>
<li>AdaptHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) shares decreased by 20.05% to $9.65. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today. </li>
<li>Bellicum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCM#NASDAQ">BLCM</a>) shares declined by 16.66% to $0.8. The company's market cap stands at $7.2 million. </li>
<li>Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) shares fell 15.85% to $6.85. The market value of their outstanding shares is at $551.7 million. The company's, Q1 earnings came out yesterday. </li>
<li>Acorda Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOR#NASDAQ">ACOR</a>) stock declined by 15.39% to $0.74. The market value of their outstanding shares is at $18.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACOR

AHCO

SYBX

TCMD

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Mobiquity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobq#NASDAQ">MOBQ</a>) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday.</li>
<li>ClearOne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clro#NASDAQ">CLRO</a>) gained 46.7% to $1.82 in pre-market trading after the company announced a special one-time cash dividend of $1.00 per share of common stock, payable May 31 to shareholders of record on May 22, 2023.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) gained 20.3% to $0.1565 in pre-market trading. Tivic Health, on Monday, launched a B2B portal.</li>
<li>Palantir Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pltr#NYSE">PLTR</a>) surged 19% to $9.21 in pre-market trading after the company reported strong Q1 results and said it expects to remain profitable each quarter through the end of the year.</li>
<li>HUB Cyber Security (Israel) Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) jumped 17.1% to $0.7492 in pre-market trading. HUB Security recently raised up to $16 million in growth investment from The Lind Partners.</li>
<li>Healthcare Triangle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcti#NASDAQ">HCTI</a>) shares climbed 16.1% to $0.2799 in pre-market trading.</li>
<li>LogicMark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) gained 15.5% to $3.58 in pre-market trading after jumping around 9% on Monday.</li>
<li>Alto Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alto#NASDAQ">ALTO</a>) climbed 11.1% to $1.51 in pre-market trading after reporting Q1 results.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) gained 10.4% to $1.49 in pre-market trading after dropping 8% on Monday. Akili recently announced the topline results of the STARS-ADHD-Adult trial evaluating EndeavorRx (AKL-T01) in adults with attention deficit/hyperactivity disorder (ADHD).</li>
<li>Clear Channel Outdoor Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cco#NYSE">CCO</a>) gained 8% to $1.36 in pre-market trading.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ohmyhome Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) fell 48% to $13.52 in pre-market trading after jumping around 329% on Monday.</li>
<li>Lexaria Bioscience Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lexx#NASDAQ">LEXX</a>) fell 23.9% to $0.78 in pre-market after the company reported pricing of $2.0 million public offering.</li>
<li>JE Cleantech Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jcse#NASDAQ">JCSE</a>) fell 18.4% to $0.6450 in pre-market trading after jumping around 60% on Monday.</li>
<li>Aptorum Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apm#NASDAQ">APM</a>) fell 13.4% to $3.15 in pre-market trading after dipping 32% on Monday.</li>
<li>Bellicum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blcm#NASDAQ">BLCM</a>) shares dropped 13% to $0.8349 in pre-market trading. Bellicum Pharmaceuticals shares jumped 146% on Monday after a 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company.</li>
<li>SMX (Security Matters) Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smx#NASDAQ">SMX</a>) fell 12.3% to $1.61 in pre-market trading after jumping 38% on Monday.</li>
<li>OKYO Pharma Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) fell 11.8% to $1.88 in pre-market trading after jumping 23% on Monday.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) fell 11.5% to $0.4380 in pre-market trading after gaining around 14% on Monday. Panbela Therapeutics recently posted a wider-than-expected quarterly loss.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) fell 11.1% to $8.08 in pre-market trading after the company reported downbeat Q1 results and announced next phase of restructuring initiative.</li>
<li>Dragonfly Energy Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfli#NASDAQ">DFLI</a>) shares fell 10.4% to $4.10 in pre-market trading. Dragonfly Energy is expected to release its financial results for the first quarter on May 15, 2023.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/05/32280110/investor-optimism-improves-ahead-of-inflation-data"> Investor Optimism Improves Ahead Of Inflation Data</a>

AKLI

DFLI

Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket

Comments

Bellicum Pharmaceuticals Inc

Bellicum Pharmaceuticals Inc (BLCM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga